Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-04 @ 4:41 PM
Study NCT ID:
NCT02862132
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2016-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Sponsor:
Shaare Zedek Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VEDOKIDS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None